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ABSTRACT
One of the key issues in studying transcriptional regulation during
development is how to employ genome-wide assays that reveals sites
of open chromatin and transcription factor binding to efficiently
identify biologically relevant genes and enhancers. Analysis of
Drosophila CNS midline cell development provides a useful system
for studying transcriptional regulation at the genomic level due to a
large, well-characterized set of midline-expressed genes and in vivo
validated enhancers. In this study, FAIRE-seq on FACS-purified
midline cells was performed and the midline FAIRE data were
compared with whole-embryo FAIRE data. We find that regions of the
genome with a strong midline FAIRE peak and weak whole-embryo
FAIRE peak overlap with known midline enhancers and provide a
useful predictive tool for enhancer identification. In a complementary
analysis, we compared a large dataset of fragments that drive midline
expression in vivo with the FAIRE data. Midline enhancer fragments
with a midline FAIRE peak tend to be near midline-expressed genes,
whereas midline enhancers without a midline FAIRE peak were often
distant from midline-expressed genes and unlikely to drive midline
transcription in vivo.
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INTRODUCTION
Tissue-specific regulation of gene expression is an important aspect
of development, but the mechanisms that determinewhich segments
of the regulatory genome are active in a given cell remain
incompletely known. While genome-wide analyses identifying
sites of open chromatin, transcription factor binding and chromatin
states are commonly carried out, it is often unclear how well these
assays are able to identify relevant regulatory elements and target
genes. Drosophila CNS midline cells provide a useful experimental
system for studying transcriptional regulation during CNS
development. The development of the midline neurons and glia is
well characterized with regards to both cellular and molecular
mechanisms (Watson et al., 2011; Watson and Crews, 2012;
Wheeler et al., 2008). Multiple large-scale screens have identified
hundreds of genes that are expressed in midline cells (along with
associated enhancers), and several transcription factors are known
that control midline cell transcription (Kearney et al., 2004; Kvon
et al., 2014; Manning et al., 2012; Tomancak et al., 2002, 2007;
Wheeler et al., 2006, 2009). In this study, we purify midline cells
from a key developmental period in which cell fate specification
occurs and perform formaldehyde-assisted isolation of regulatory
elements (FAIRE) analysis (Giresi et al., 2007) to initiate a genome-
wide characterization of midline cell chromatin states. These data
allow us to use the unique breadth of existing in vivo midline cell
data to examine the relationships between chromatin accessibility,
transcriptional enhancer activity, and cell type-specific gene
expression in developing animals.
The Drosophila embryonic CNS midline cells consist of ∼22
neurons and glia per segment (Wheeler et al., 2006). The neurons
are diverse and consist of GABAergic and glutamatergic
interneurons and peptidergic and neuromodulatory motoneurons.
The midline glia ensheath the commissural axons that cross the CNS
and act as a key embryonic signaling center (Crews, 2009; Jacobs,
2000). There are three discrete phases of CNS midline cell
development (Kearney et al., 2004). The initiation of midline cell
development occurs during the mesectodermal stage (embryonic
stages 5-8), mainly due to the activation of single-minded (sim)
expression (Nambu et al., 1991). Formation of the midline
primordium cells (stages 9-12) involves specification of neural
precursors and midline glia by multiple signaling pathways (Watson
et al., 2011; Watson and Crews, 2012; Wheeler et al., 2008),
followed by division and development into neurons and glia. At the
late embryonic midline stages (stages 13-17), the midline neurons
complete terminal differentiation and the midline glia complete
their apoptotic and migration steps to form the glial scaffold that
supports the axon commissures.
One long-standing aspect of the study of Drosophila CNS
midline cell development has been transcriptional control. This has
been due, in part, to the multiple genome-level resources that exist to
support the study of midline cell development and transcription. The
Berkeley Drosophila Genome Project (BDGP) gene expression
database has embryonic in situ hybridization (ISH) data on 7559
genes, including annotation for midline expression (Tomancak
et al., 2002, 2007). The Midline Gene Expression Database
(MidExDB) expanded on the BDGP effort and is focused on ISH
data exclusively related tomidline expression (Wheeler et al., 2009).
Another resource is the transcriptomic profile of midline cells
from RNA-seq analyses of FACS-purified midline cells at two
developmental periods, namely 6-8 h after egg laying (AEL) and
14-16 h AEL (Fontana and Crews, 2012). In addition, two large-
scale projects were carried out to identify the transcriptional
enhancers that regulate gene expression. Through cloning of
thousands of genomic fragments for transgenic reporter analysis,
the Janelia Research Campus (JRC) FlyLight project identified 438
fragments with enhancer activity associated with 253 genes that
drive strong embryonic midline expression (Manning et al., 2012).Received 2 March 2016; Accepted 30 August 2016
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Similarly, the Vienna Fly Enhancer project identified 187 midline
lines (Kvon et al., 2014). Although the FlyLight and Vienna
collections have provided a deeper understanding of the
transcriptional regulatory capacity of animal genomes, the extent
to which the activity of DNA fragments in reporter assays reflects
the activity of these DNAs in their natural genomic contexts is
unclear.
These genomic datasets, along with a well-characterized genetic
understanding of midline cell development, provide a powerful
system for mechanistically studying the transcriptional control of
CNS development. To generate a genome-wide map of functional
DNA regulatory elements in developing CNS midline cells, we
performed FAIRE-seq (Giresi et al., 2007), which isolates
nucleosome-depleted genomic regions, including transcriptional
enhancers and promoters. The relatively low chromatin input
required for FAIRE-seq allowed us to assay chromatin accessibility
in FACS-isolated midline cells, which comprise less than 1% of
Drosophila embryonic cells (Fontana and Crews, 2012). Chromatin
accessibility profiles from FACS-isolated midline cells show a high
degree of correspondence with previously identified midline
enhancers. In this study, we show the utility and necessity of
combining FAIRE-seq data from purified midline cells with data
fromwhole-embryo cells to identify biologically relevant enhancers
with a high degree of certainty. We further compare the FAIRE-seq
data with the multiple midline expression and enhancer datasets to
explore the predictive utility of the FAIRE data in identifying and
understanding the biological relevance of midline enhancers.
RESULTS
Midline cell FAIRE-seq reveals cell type-specific open
chromatin
To generate open chromatin profiles from midline cells, we used
FACS to isolate GFP+ cells from dissociated sim3.7-Gal4 UAS-
mCD8::GFP embryos (Fontana and Crews, 2012). The sim3.7-
Gal4 transgene drives expression in only CNS midline cells and a
small group of gut cells (Fig. 1A). We performed two replicates.
Populations of midline cells (390,000 and 250,000 cells) were
isolated from two independent collections of embryos at 6-8 h AEL,
corresponding to mid-stage 11 to early stage 12 (Campos-Ortega
and Hartenstein, 1997) (Fig. 1B). These cells are referred to as
midline primordium cells and are just beginning to differentiate into
midline neurons and glia. After sorting, cells were briefly fixed with
formaldehyde, frozen, subjected to FAIRE, and the resulting DNA
sequenced on an Illumina HiSeq. Despite the technical challenges
presented by isolating GFP+ cells from whole embryos, FAIRE
replicates were well correlated (Fig. 1C), with a Pearson’s
coefficient of 0.7. MACS2 analysis (Zhang et al., 2008) of the
pooled data identified 15,191 peaks of open chromatin (Fig. 1B).
Midline cells represent a small fraction of the embryo; for
example, only 0.7% of the sorted cells were GFP+. Thus, it is
possible that chromatin accessible only in midline cells would not
be detected in assays performed on whole embryos. To identify
regions of chromatin accessibility that are specific to midline cells,
we compared midline FAIRE (MF) data with whole-embryo FAIRE
(EF) data from the same 6-8 h developmental stage (McKay and
Fig. 1. FAIRE-seq analysis of FACS-isolated Drosophila CNS midline cells. (A) Stage 11 sim3.7-Gal4 UAS-mCD8::GFP embryo (ventral view, anterior left)
stained with anti-GFP (green) shows midline cells (each bracket denotes a single embryonic segment; ∼20 midline cells) and a small group of stomodeal
cells (arrowhead). (B) Summary of FACS sorting data from two independent midline FACS samples (Rep1 and Rep2). (C) Scatterplot of midline FAIRE (MF)
signals of the top 10,000 FAIRE peaks from replicates of FACS-sorted midline cells. Pearson’s coefficient (R) is shown. (D) Scatterplot of FAIRE signals of the
top 10,000 FAIRE peaks from FACS-sorted midline cells (MF) and stage-matched whole-embryo cells (EF). Red dots indicate differentially accessible peaks, as
determined by edgeR (FDR ≤0.05).
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Lieb, 2013). Genome-wide, the chromatin accessibility profiles in
midline cells are similar to those from whole embryos at the same
developmental stage (Fig. 1D), suggesting that many DNA
regulatory elements are equivalently accessible in both midline
and non-midline cells. However, we also noticed regions of high
chromatin accessibility that were specific to midline cells or to
whole embryos. Using edgeR to define FAIRE peaks with
differential accessibility (Robinson et al., 2010), we identified 167
peaks with greater accessibility in midline cells (FDR ≤0.05;
hereafter referred to as ‘midline-enriched’ FAIRE peaks; Table S1)
and 942 peaks with greater accessibility in whole embryos (red dots
in Fig. 1D). Thus, while chromatin accessibility is similar between
whole embryos and midline cells, there are regions enriched only in
midline cells and other regions that are relatively inaccessible in
midline cells relative to whole embryos.
Midline FAIRE peaks correspond to known midline
enhancers
Chromatin accessibility correlates with DNA regulatory sequence
activity of promoters, enhancers and other elements (e.g. McKay
and Lieb, 2013). In the sections below, we employ five datasets
of midline-expressing enhancers and genes (see Introduction) to
address the significance of the MF data. Use of the midline
enhancer, midline ISH gene expression, and RNA-seq datasets
allows us to interpret the FAIRE data within the context of in vivo
relevant midline-expressed genes and regulatory elements.
The first dataset that we examined included 19 midline enhancers
associated with midline primordium-expressed genes (referred to as
‘canonical’ midline primordium enhancers) that were described in
previous publications (Table S2) and are active during our 6-8 h
FAIRE assay window (‘midline primordium’; 5-9 h AEL). All 19
midline primordium enhancers have an MF peak, whereas only ten
have a corresponding EF peak (Fig. 2A). Consistent with this
observation, ten of the midline primordium enhancers contain a
midline-enriched peak (edgeR FDR≤0.05), indicating that midline-
specific enhancers often possess midline-enriched chromatin
accessibility (Fig. 2A, ML-EN; Table S2). Five enhancers have
been localized to a resolution of ∼500 bp, about the size of the
FAIRE peaks (Table S2), indicating a strong correspondence between
the MF peak and enhancer. Analysis of the 19 midline primordium
enhancers indicates that these enhancers all have an MF signal that is
larger than the EF signal (Fig. 2B), even though nine have an FDR
>0.05. We also analyzed a published set of 78 enhancers that do not
drive midline expression when tested in vivo but are active in other
cell types at the same stage 11-12 period. These fragments have
significantly lower MF signals and MF/EF ratios (Fig. 2B) than the
midline primordium fragments. Thus, enhancers active in midline
primordium cells overlap regions of open chromatin in midline cells,
whereas enhancers active in other tissues at the same stage do not.
Midline FAIRE peaks overlap with enhancers in the sim
master regulatory gene locus
The correspondence between MF peaks and enhancers that drive
midline expression can be readily visualized by examination of
well-characterized midline-expressed genes, such as Drosophila
sim, a master regulator of CNS midline cell transcription and
development (Nambu et al., 1990, 1991). sim is prominently
expressed in midline cells throughout embryonic development,
including the midline primordium stage (Thomas et al., 1988). It is
also expressed in subsets of cells along the midline of the foregut
and midgut (Nambu et al., 1990) and transiently in a subset of
developing muscle cells (Lewis and Crews, 1994).
Embryonic transcription of sim proceeds from two promoters: the
early promoter (PE) and the late promoter (PL) (Fig. 2C-E) (Kasai
et al., 1998; Muralidhar et al., 1993; Nambu et al., 1990). Previous
work has shown that, at 6-8 h, transcription is predominantly
derived from PL. This is confirmed by the 6-8 h MF and EF data
(Fig. 2F,G), which show a peak of open chromatin at PL (peak b)
but not PE. There are at least four distinct midline primordium
enhancers at the sim locus, as indicated by in vivo-tested fragments
(1.0, 0.7, R15F08, 1.6; Fig. 2H) (Freer et al., 2011; Manning et al.,
2012; Muralidhar et al., 1993; Sandmann et al., 2007; Wharton
et al., 1994). The MF data reveal a total of eight strong MF peaks
(a, c-i). Five of theMF peaks (c, f, g, h, i) do not overlap a significant
corresponding EF peak, and one peak (a) incompletely overlaps an
EF peak (b) that is likely to reflect open chromatin at the PL
promoter. Peaks c, f, h and i are midline enriched (FDR ≤0.05). All
four distinct midline primordium enhancers overlap an MF peak
(1.0 with a, 0.7 with c, R15F08 with f/g, 1.6 with h/i). Interestingly,
the 0.7 fragment drives midline expression, but larger fragments that
encompass 0.7 do not; this includes 0.96, which is not much larger
than 0.7. The presence of peak c overlapping the 0.7 enhancer
provides support that this region is used in vivo to drive midline
expression. Similarly, we propose that peak f is a midline enhancer
and the previously uncharacterized E2.3 fragment that includes
peak f drives midline expression (Fig. 2I). In addition, peaks h and i
might represent distinct enhancers. Interestingly, the two MF peaks
(d, e) with corresponding strong EF peaks do not drive strong
midline primordium expression. Peak d does not drive embryonic
6-8 h expression (C2.3; Fig. 2J), and peak e overlaps two fragments
(VT40840 and D2.1) that drive relatively weak midline expression,
as well as non-midline expression (Fig. 2K) that does not
correspond to endogenous sim expression.
In summary, all sim midline primordium enhancers identified
by in vivo enhancer testing have corresponding 6-8 h MF peaks,
including four midline-enriched MF peaks. Similarly, all 6-8 h MF
peaks without significant corresponding EF 6-8 h peaks overlap a
fragment with midline enhancer activity. Remarkably, the sim gene
has potentially seven distinct enhancers that drive midline
primordium expression in addition to another enhancer that drives
mesectodermal expression.
FAIRE identifies multiple new midline enhancers in the
engrailed/invected locus
The preceding analysis of the sim locus demonstrated the utility of
open chromatin profiling from purified cells to identify tissue-
specific enhancers that might not be detected in whole embryo
experiments. We next sought to test whether these data can be used
to identify previously unknown midline enhancers. The engrailed
(en) and invected (inv) genes are both expressed in midline and non-
midline cells, as shown by ISH and RNA-seq from isolated cell
populations (Fig. 3A-C,H). However, identification of midline
enhancers has been hampered by the size of the locus (110 kb) and
its complex organization (Gustavson et al., 1996). We used
previously uncharacterized fragments from the FlyLight collection
(Manning et al., 2012) to test whether midline FAIRE can predict
midline enhancer activity.
There are eight substantial MF peaks (a-h) in the en/inv locus that
we considered (Fig. 3D,E). Two of these regions (a, d) correspond
to the inv and en promoters. Three of these regions (c, e, h) are
accessible in both midline cells and whole embryos. Consistent with
this observation, regions c and h overlap fragments from the
FlyLight and Fly Enhancer (Kvon et al., 2014) collections that drive
broad expression in bothmidline and non-midline cells (region ewas
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not cloned in either project, and its pattern of activity was not
assayed). Most interesting are three regions that are more highly
accessible inMF than in EF (b, f, g), although none of the three peaks
is midline enriched (FDR ≤0.05). Each of these midline-specific
accessible regions overlaps a fragment that was cloned to generate
transgenicGal4 lines by FlyLight (Fig. 3F). The expression patterns
controlled by these fragments were previously untested, providing an
opportunity to test the predictive value of midline-specific open
Fig. 2. Midline enhancers contain midline-enriched FAIRE peaks. (A) Canonical midline primordium enhancers from 19 midline-expressed genes were
analyzed for the presence of: (1) an MF peak; (2) a midline-enriched MF peak (FDR ≤0.05) (ML-EN peak); and (3) an EF peak. (B) Plots of the FAIRE log2 signal
ratio (MF/EF) for canonical enhancers active during the 6-8 h FAIRE assay window. Each dot represents one enhancer. Midline primordium enhancers have
significantly higher MF/EF values than non-midline enhancers (Mann–Whitney U-test, P=1.8×10−9). The two horizontal lines in each data column represent the
median value for each set of enhancers. (C-H) UCSC Genome Browser tracks at the sim locus. (C,D) Non-midline and midline 6-8 h embryonic RNA-seq data
indicating strong midline expression of sim. (E) Schematic of sim gene structure with early (PE) and late (PL) promoters of sim indicated, with arrows showing
transcriptional orientation. Boxes indicate exons and lines signify introns. Tall boxes indicate coding sequence and shorter boxes denote untranslated regions.
(F,G) FAIRE-seq data from (F) 6-8 h whole embryo FAIRE (EF) and (G) 6-8 h midline FAIRE (MF). Letters (a-i) identify significant FAIRE peaks. (H) Boxes
represent FlyLight, Fly Enhancer and published enhancers. Colors indicate activity: green, midline primordium expression; pink, mesectodermal expression;
blue, midline expression after stage 12; orange, broad expression that may include midline expression; black, no midline expression. Vertical dashed columns
indicate predicted midline enhancers from MF peaks (blue) and the PL promoter corresponding to FAIRE peak b (orange). (I-K) Expression of selected sim gene
enhancers at stage 11. Expression is revealed by Gal4 fluorescent ISH of ventral views of strains (I) simE2.3-Gal4, (J) simC2.3-Gal4 and (K) simD2.1-Gal4.
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chromatin for transcriptional regulatory activity. We assayed the
expression of each line by ISH for Gal4 and anti-GFP
immunostaining of embryos also possessing UAS-mCD8::GFP.
All three fragments drive strong midline expression during stages
11-12 (Fig. 3I-K). More detailed analysis of the FlyLight Gal4
lines revealed that all three fragments drive expression in distinct
posterior midline subsets of the endogenous en/inv pattern
(Fig. S1), which is likely to reflect the complexities of en/inv
midline function (Watson et al., 2011; Watson and Crews, 2012;
Wheeler et al., 2006). Subsequently, the publication of the
Fly Enhancer database (Kvon et al., 2014) (Fig. 3G) and a
transgenic dissection of the en/inv locus (Cheng et al., 2014) also
revealed that peaks f and g overlap fragments that drive midline
expression; the overlaps between R94C12 and VT15161, and
between R94D05 and VT15169, occur over the MF peaks
(Fig. 3E-G).
In summary, FAIRE analysis from sorted midline cells reveals
three prominent accessible regions at the en/inv locus that are
specific to midline cells, and each of these regions overlaps a
fragment that controls expression in a subset of the endogenous
en/inv pattern. Thus, by leveraging high-throughput transcriptional
reporter databases, such as FlyLight and the Fly Enhancer
collection, sorted-cell FAIRE data can be used to successfully
pinpoint the location of in vivo relevant enhancers that are active
even in a small percentage of cells from a complex genetic locus.
Midline-enriched FAIRE peaks efficiently identify midline-
expressed genes
The results described above indicate that 19 canonical midline
primordium enhancers each contain a high-ranking MF peak and a
low-ranking or absent EF peak. Ten of the enhancers had a midline-
enriched MF peak (FDR ≤0.05). We also showed in the case of
en/inv how the appearance of high MF/EF ratio peaks could be used
to predict midline enhancers. Consequently, we asked what fraction
of the 167 midline-enriched peaks is associated with midline-
expressed genes (and presumed midline enhancers). This analysis is
greatly facilitated by the existence of the BDGP and MidExDB ISH
data and our midline and whole-embryo RNA-seq data, since these
resources reliably detect midline expression for most of the genome.
Each peak was scanned in the UCSC browser for nearby genes and
these genes assessed for embryonic expression using RNA-seq and
ISH data; ISH expression data were present for 89% of the nearby
genes analyzed. The peaks were sorted into four groups (see Fig. S2
for examples). The first group contained peaks near or within
prominent midline-expressed genes (Table S1, ‘Midline’; Fig. S2A,B).
This group consists of 59 midline-enriched MF peaks and
constitutes 35% of the total midline-enriched peaks (Table S3),
demonstrating the strong utility of this identifier for recognizing
midline-expressed genes. Of these 59 peaks, 31 overlap known
enhancers from canonical, FlyLight or the Fly Enhancer collections;
24 of those enhancers drive strong midline expression, whereas the
Fig. 3. Midline FAIRE reveals multiple midline enhancers in the inv/en locus. (A-G) UCSC Genome Browser tracks corresponding to the inv/en locus.
(A,B) RNA-seq indicating strong expression of inv and en in midline cells at 6-8 h AEL. (C) Schematic of the inv/en locus. (D,E) Data from (D) 6-8 h EF and
(E) 6-8 h MF. Letters (a-h) identify significant MF peaks. Blue vertical columns correspond to MF peaks that match in vivo-tested midline enhancers and orange
columns indicate FAIRE peaks that correspond to inv and en promoters. (F,G) Boxes indicate (F) FlyLight and (G) Fly Enhancer fragments. Colors indicate
activity: green, midline primordium expression; orange, broad expression that may include midline expression; black, no midline expression; gray, untested.
(H-K) Ventral views of stage 11 embryos hybridized in situ to (H) an en probe and (I-K)Gal4 probes; arrowheads indicate midline cells. (H) Fluorescent ISH with en
probe showing ectodermal stripes andmidline expression. (I) Strong midline expression in posterior midline cells of anR88F11-Gal4 strain. (J)R94C12-Gal4 drives
expression in a subset of posterior midline cells and weakly in ectodermal stripes. (K) R94D05-Gal4 drives expression in a small group of posterior midline cells.
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other seven do not (Table S3). The 59 peaks correspond to 43
distinct gene loci, many of which are well-studied, prominent
midline-expressed genes. However, we also were introduced to a
number of genes whose midline expression was not known to us
(Ank2, dnr1,mirr, sick), further indicating the utility of theMF data.
We documented the midline expression of mirr by ISH (Fig. S3).
The second, smaller group of midline-enriched enhancers are
found in genes with broader CNS expression as determined by ISH;
midline expression is present but much less prominent compared
with the Midline group genes mentioned above (Table S1, ‘Broad’;
Fig. S2C). Within this group, the midline-enriched MF peak may
potentially contribute to the midline expression component. There
were 18 peaks corresponding to 18 gene loci in the Broad group,
accounting for 11% of the total peaks (Table S3). RNA-seq data for
these genes (Table S1) consistently show significant midline
expression. Known enhancers overlap five peaks; one drives
midline expression and four do not. Combined with the Midline
group, these two groups constitute 46% of the midline-enriched
MF peaks.
The third group of midline-enriched MF peaks resides near genes
expressed in the gut (Table S1, ‘Gut’; Fig. S2D). This is not
surprising, since the 3.7sim-Gal4 UAS-mCD8::GFP strain used to
isolate the midline cells also expresses GFP in a subset of gut cells
(Fig. 1A) and gut expression of sim was previously described
(Nambu et al., 1990). There are 40 peaks (24% of total) that
correspond to 35 genes with prominent gut expression (Table S3).
When the Gut, Midline and Broad group peaks are combined, 70%
of the midline-enriched peaks correlate with relevant enhancers
(midline and gut) active in the sorted cells. This leaves only 50
peaks (30% of the total) that are not obviously associated with a
potentially relevant enhancer or gene (Table S1, ‘None’).
Overall, these data indicate the utility of comparing FAIRE-seq of
purified cells with whole embryo FAIRE-seq to identify cell type-
specific enhancers. In addition, the data indicate that the purer the
starting cells, the more useful the results. Why don’t all midline-
enriched peaks correspond to midline or gut-expressed genes?
Some midline-enriched peaks and corresponding open chromatin
might simply not act as a midline or gut enhancer; other reasons
include: (1) a lack of ISH expression data that, if present, would
indicate the existence of a nearby midline or gut-expressed gene and
(2) the ability of enhancers to act over long distances.
DNA binding motifs are variably enriched among different
classes of midline-enriched FAIRE peaks
The four groups of midline-enriched FAIRE peaks were each
analyzed for over-represented DNA-binding site motifs of prominent
midline primordium transcription factors using a collection of tools
from the MEME suite and transcription factor position weight
matrices (PWMs) from Fly Factor Survey (http://mccb.umassmed.
edu/ffs) (Fig. 4) (Bailey et al., 2015; Meng et al., 2005). In the
Midline group of peaks, the most prominent over-represented motif is
ACGTG, which corresponds to the binding site for Sim-Tgo (Bailey
et al., 2015; Meng et al., 2005). This reinforces the association of
these peaks with midline enhancers and the prominent role of Sim-
Tgo in controlling midline gene regulation. The next highest motif
corresponds to the binding sites for homeobox transcription factors,
including midline-expressed Ocelliless (Oc). Three additional over-
represented sites correspond to Pointed (Pnt), Ventral veins lacking
(Vvl) and En, which play prominent roles in midline transcription.
Motif analysis of the Broad, Gut and None groups did not reveal
any strongly over-represented motifs other than a modest over-
representation of a homeobox-related motif in the Gut and None
groups and for the Sim-Tgomotif in the Gut group. Directly counting
the instances of ACGTG motifs revealed that 47/59 Midline group
peaks contained an ACGTG motif (80%), with a mean of 1.56
ACGTGs/peak, significantly greater than the background mean of
0.66 (P<0.0001). The Midline group ACGTG frequency was also
significantly greater (P=0.01) than the occurrence of ACGTG motifs
in the Broad group, in which 10/18 peaks had an ACGTG (56%),
with a mean of 0.83 ACGTGs/peak, not significantly different from
the background mean of 0.63 (P=0.33). Similarly, the Gut group had
21/40 (52%) peaks with an ACGTG motif, with a mean of 0.85
ACGTGs/peak, similar to the background mean of 0.60 (P=0.14).
Geneswith strongmidlineexpression haveabundantmidline
FAIRE peaks
Because of the ease of identifying midline primordium gene
expression, most genes with strong midline expression are known.
The MidExDB database currently lists 164 genes with midline
primordium expression in all or a subset of midline cells. These
genes vary significantly in the levels of midline expression.
Reanalyzing the ISH data, 37 genes are noteworthy for having
strong midline primordium expression (Table S4). This is reinforced
by a median midline cell RNA-seq FPKM value of 142.52 and
median ratio of midline RNA-seq/whole-embryo RNA-seq FPKMs
of 8.9 for the 37 genes. Examining each gene for the occurrence of
MF peaks indicates that each has an MF peak varying in number
from 1 to 39. The median number of MF peaks/gene is 10.1. There
are 22 genes (59%; 22/37) with at least one midline-enriched (FDR
≥0.05) peak. There are a total of 50 midline enhancers associated
with 28 of the genes and 90% (45/50) overlap with an MF peak.
These data further indicate that genes with strong midline
expression have enhancers that can be recognized by the
occurrence of midline-enriched or other high-ranking MF peaks.
Not all midline enhancers have a midline FAIRE peak, but
those with midline-enriched peaks reside near midline-
expressed genes
Having established that most midline-expressed genes have a
corresponding MF peak, we addressed a different, but related
question: what fraction of midline enhancers identified by in vivo
testing have MF peaks and are associated with (and likely control the
expression of) midline-expressed genes?We focused our analysis on
the Fly Enhancer Gal4 lines, which were analyzed by ISH and thus
closely reflect the dynamics of enhancer activity. We omitted the
FlyLight data because analysis was by anti-GFP immunostaining,
and in some cases, the ‘midline primordium’ expression might be
due to GFP protein perdurance from enhancers active at earlier
developmental stages. We examined each enhancer for the presence
of an MF peak and its location with respect to midline-expressed
genes (Table S5). In the Fly Enhancer collection there are 102 non-
overlapping fragments that drive expression at the midline
primordium stage. Of these fragments, 20 (20% of total) have a
midline-enriched MF peak, of which 17/20 (85%) reside near a
midline-expressed gene (Table S6). This indicates that regulatory
elements in the genome with a midline-enriched MF peak that drive
expression in a transgenic assay are likely to be used in vivo. More
common are fragments that have MF peaks but with edgeR FDR
values >0.05. There were 49 members of this category (48% total)
and 22 reside near a midline-expressed gene (45%). Thus, a midline
enhancer with a lower rankingMFpeak still has almost a 50%chance
of being associated with a midline-expressed gene. The final class is
midline enhancers that do not have an MF peak. There were 33
members of this class and only eight reside near a midline-expressed
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gene (24%). As an example, a fragment (VT39752) from intron 1 of
CG34114 (Fig. 5C,F) drives strong midline expression from late
stage 11 through stage 16 (Kvon et al., 2014). Yet, the CG34114
gene does not have an MF or EF peak (Fig. 5D,E), and CG34114
expression is not detected in 6-8 h midline or non-midline cells
(Fig. 5A,B); nor are the adjacent CG4683 and CG6629 genes
expressed in midline cells as assessed by RNA-seq or ISH.
Consistent with the weak expression, the CG34114 locus lies
within a 174 kb region lacking histone modifications in whole
embryos, which typically corresponds to regions of low gene activity
(Ho et al., 2014) (Fig. 5C; see below). Not surprisingly, the average
strength of the midline enhancers as measured by the Fly Enhancer
group is significantly higher for those with a midline-enriched MF
peak (3.0) than for enhancers with a lower ranking MF peak (2.4;
P=0.0037) or without a peak (2.3; P=0.0117) (on a scale of 1-4, with
4 having the highest levels; Table S5) (Kvon et al., 2014).
Overall, 55/102 (54%) of the midline enhancer fragments do not
reside near a known midline-expressed gene and presumably are not
active in midline cells; instead, the midline activity of these
fragments might be a consequence of being removed from the
natural genomic context. In summary, fragments that drive midline
primordium expression and contain midline-enriched FAIRE peaks
generally reside near midline-expressed genes (85%), those
fragments with lower ranking MF peaks are closely split between
those associated with a midline-expressed gene (45%) and those
without (55%), whereas fragments lacking an MF peak tend not to
reside near midline-expressed genes (76%) and are unlikely to drive
midline expression in vivo.
Examination of the location of the enhancers with respect to
modified histone chromatin states (Ho et al., 2014) reinforces the
distinction between enhancers with an MF peak and those without.
Of the midline enhancers with an MF peak, whether midline
enriched or not (Fig. S4; MF), 25% lie within chromatin with an
‘enhancer’ chromatin profile and 39% have a ‘Polycomb-repressed’
chromatin profile – both chromatin states are associated with
developmentally regulated genes. Only 6% of the enhancers
without an MF peak reside in ‘enhancer’ chromatin and 24%
reside within ‘Polycomb-repressed’ chromatin (Fig. S4; No MF).
Fig. 4. Motif analysis of midline-enriched peaks reveals binding sites for Sim-Tgo. (A) MEME analysis of motif enrichment (AME) of the four groups of
midline-enriched peaks with motifs from prominent midline primordium-expressed transcription factors revealed over-representation of Sim-Tgo binding sites in
the ‘Midline’ group, alongwith sites for themidline-localized transcription factorsOc, Pnt, Vvl and En.Motifs corresponding to themidline transcription factors were
not over-represented in the other groups, except for a modest over-representation of the Oc homeobox motif in the ‘Gut’ and ‘None’ groups and Sim-Tgo in the
‘Gut’ group. Heatmap showsmotif enrichment for the corresponding transcription factor binding sites. (B) Position weight matrix sequence logos are shown for the
five transcription factors, along with corresponding P-values.
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By contrast, regions associated with low gene activity (‘low’ histone
modified or ‘heterochromatin’ chromatin) are present in enhancers
with an MF peak at a low frequency of 7%, whereas 45% of
the enhancers without an MF peak were present in the low gene
activity chromatin states. These data support the view that midline
enhancers with an MF peak (enriched and not-enriched are similar;
Fig. S4) tend to reside in chromatin regions associated with active
transcription (64%) and infrequently in inactive regions (7%),
whereas midline enhancers without an overlapping MF peak are
commonly in inactive chromatin regions (45%) and less frequently
in active regions (30%).
DISCUSSION
We have examined the utility and limits of cell type-specific
FAIRE-seq as an assay to identify biologically relevant enhancers
throughout the genome. Our analysis utilized purified Drosophila
CNS midline cells for FAIRE-seq, and compared the data with
large-scale, developmentally matched ISH, RNA-seq, and enhancer
expression datasets. These data allow us to draw a number of
conclusions about how to assess the in vivo validity of enhancers.
The first point regards the use of FAIRE data to identify in vivo
relevant, cell type-specific enhancers, which is one of its most
important functions. In this study, we demonstrate the utility of
matching midline FAIRE (MF) data to whole-embryo FAIRE (EF)
data for enhancer recognition.We identified 15,191 6-8 hMF peaks.
Most of the MF peaks are unlikely to correspond to relevant midline
primordium enhancers and promoters. However, comparing the MF
peaks with whole-embryo (EF) peaks using edgeR revealed a group
of only 167 peaks that were ‘midline-enriched’ to an edgeR FDR
value ≤0.05. Comparing the presence of these peaks with known
midline enhancers and midline-expressed genes indicates that a
relatively large number are likely to correspond to in vivo relevant
enhancers. They are over-represented in Sim-Tgo binding sites and
have predictive value. There are additional MF peaks that possess a
high ME/EF ratio but have an edgeR value >0.05 that correspond to
in vivo relevant midline enhancers. Our data strongly indicate that
genes with prominent midline primordium expression contain one
or more MF peaks and these peaks generally correspond to midline
enhancers. Since the GFP-sorted midline cells also contained some
gut cells, some midline-enriched peaks were near genes expressed
in gut cells. Although this extends the success of FAIRE-seq to
identify relevant genes and enhancers, it also reinforces the need to
use highly purified cell populations.
While a significant fraction (59%) of the 167 midline-enriched
edgeR peaks reside near strong midline (and gut)-expressed genes
and most peaks are likely to correspond to cell type-specific
enhancers, the significance of the other 41% of midline-enriched
peaks remains an open question. One class of midline-enriched
peaks was associated with genes that are broadly expressed,
including in midline cells, although the midline expression is
generally weak (Broad group; 11% of the midline-enriched peaks).
One hypothesis is that the midline-enriched MF peak is an enhancer
element that contributes to the midline component of the expression
pattern of the gene. However, these peaks are not over-represented
in Sim-Tgo binding sites (although this might be expected for an
enhancer with modest midline activity), and one of the five tested
overlapping DNA fragments has significant midline enhancer
activity. Thus, it is presently unclear whether the Broad group of
midline-enriched peaks commonly contributes to midline gene
expression. The members of the final group (30%) are not clearly
associated with any midline or gut-expressed genes and their
significance is unknown. Still, by combining the MF and EF data to
identify a small set of midline-enriched peaks, we can identify genes
with relevant expression and enhancers with a likelihood of success
Fig. 5. The VT39752 midline primordium enhancer does not reside near a midline-expressed gene. (A-F) Example of a gene locus with a strong midline
enhancer that resides far from a knownmidline-expressed gene. TheCG34114 gene (C) contains a strong 11-12 h midline intronic enhancer (F; VT39752) (Kvon
et al., 2014), yet the gene is not expressed in midline cells (A,B) and contains no significant (D) MF or (E) EF peaks. The CG34114 gene is flanked by two
expressed repeats (red boxes), as detected by RepeatMasker (http://www.repeatmasker.org/, current version: open-4.0.5) and resides in an embryonic region
lacking histone modifications (Low-signal chromatin; bar at bottom of C). (F) Boxes indicate FlyLight enhancer fragments. Colors indicate activity: green, midline
primordium expression; purple, mesectodermal expression; black, no midline expression.
3730
RESEARCH ARTICLE Development (2016) 143, 3723-3732 doi:10.1242/dev.136895
D
E
V
E
LO
P
M
E
N
T
approaching 50% or higher. It is worth emphasizing that all well-
characterized midline enhancers of midline-expressed genes
(Table S2) have a corresponding MF peak that is either midline
enriched or has a high MF/EF ratio. Thus, combining cell type-
specific and whole embryo data can identify candidate cell type-
specific enhancers with a strong degree of certainty.
Another related issue concerns the relationship between genomic
fragments that drive midline expression using in vivo enhancer
assays to the presence or absence of MF peaks. The Fly Enhancer
dataset contains 102 non-overlapping midline primordium
enhancers, allowing a robust assessment. Midline-enriched peaks
are present on 20% of the midline enhancer fragments and these
generally correspond to midline enhancers residing near midline-
expressed genes (85%). Another 48% of the fragments have an MF
peak with an edgeR value >0.05 and 45% of these enhancers reside
near a midline-expressed gene. Thus, most midline enhancer
fragments have MF peaks and the majority reside near midline-
expressed genes. A third class of midline enhancer fragments (32%)
does not have anMF peak, and 76% of these fragments do not reside
near a midline-expressed gene. Although it is possible that some
function in vivo as midline enhancers for genes that reside a large
distance away (Kvon et al., 2014), it seems likely that many of these
fragments do not function in vivo as midline enhancers. This is
reinforced by their common occurrence in regions of the genome
associated with low transcriptional activity. Considering all 102
fragments with midline primordium activity, 55% of the fragments
do not reside near a known midline-expressed gene. Other studies
have concluded that gene expression is frequently unaffected by
transcription factor binding (Cusanovich et al., 2014) and fragments
tested for enhancer activity occasionally show patterns that do not
accurately reflect expression of the nearby gene (Kvon et al., 2014).
However, in this study we provide evidence that enhancers with
specific patterns of activity (midline) frequently reside in inactive
chromatin regions and are unlikely to be employed in vivo despite
their enhancer potential.
In summary, we find that the identification of biologically
relevant cell type-specific enhancers requires the purification of
the relevant cell type and the use of open chromatin profiling
(FAIRE-seq, ATAC-seq, DNase-seq) on chromatin from both
purified cells and whole embryos. Only in this manner can one
identify cell type-specific enhancers with a fair degree of certainty.
MATERIALS AND METHODS
Fluorescence-activated cell sorting (FACS) and cell fixation
Embryo collection, dissociation, and sorting of GFP+ cells from sim3.7-
Gal4 UAS-mCD8::GFP embryos were performed as previously described
(Fontana and Crews, 2012), except that a Dounce homogenizer was used to
dissociate embryos, and cells were resuspended in Hemolymph-Like (HL)
buffer (Salmand et al., 2011). GFP+ cells were sorted as 100,000 cell batches
into cold HL buffer, fixed for 5 min with 1% formaldehyde, and quenched
with 125 mM glycine for 5 min. Fixed cells were pelleted for 5 min at
2000 g and washed twice in 10 mM HEPES in 1×PBS, and then frozen in
liquid nitrogen.
FAIRE-seq
FAIRE was performed as previously described (McKay and Lieb, 2013).
FAIRE-seq libraries were sequenced on an Illumina HiSeq 2000 at the UNC
High-Throughput Sequencing Facility. Reads were mapped to the dm3
D. melanogaster reference genome with bowtie2 (Langmead and Salzberg,
2012). Reads with a map quality score <10 were removed using SAMtools
(Li et al., 2009). FAIRE peaks were called on pooled MF data with MACS2
(Zhang et al., 2008) using genomic DNA reads as an input control sample
and an extension size of 125 bp. The top 10,000 sorted MF peaks were used
in downstream analysis. For consistency, an equal number of EF peaks was
also used. Differentially accessible peaks were determined with edgeR
(Robinson et al., 2010) using the ‘classic analysis’. FAIRE peaks with an
edgeR FDR ≤0.05 were called as ‘midline-enriched’.
RNA-seq data
RNA-seq data from Fontana and Crews (2012) were mapped to D.
melanogaster genome release dm3 with TopHat (Kim et al., 2013) and
BedGraph files were generated using BEDTools (Quinlan and Hall, 2010).
Motif prediction
DNA sequences corresponding to the 167 midline-enriched MF peaks were
analyzed using the AME tool within the MEME suite (McLeay and Bailey,
2010) for over-representation of the binding site motifs of a set of midline-
primordium-expressed transcription factors. DNA sequences corresponding
to the top 10,000 EF peaks were used as the control. The position weight
matrices (PWMs) for these midline transcription factors were obtained from
the Fly Factor Survey database (Zhu et al., 2011).
Chromatin state analysis
The chromatin state of Fly Enhancer fragments with reported midline
activity was determined by intersecting with the hiHMM dataset from late
embryos (Ho et al., 2014) using BEDTools, requiring a greater than 50%
overlap.
Generation and analysis of transgenic Drosophila strains
sim0.96 was cloned into the hsp70 promoter-nucGFP pMintgate vector
(Jiang et al., 2010) to assay its enhancer ability. The Gal4 lines simC2.3,
simD2.1 and simE2.3 were described previously (Freer et al., 2011).
FlyLight Gal4 enhancer lines were obtained from the Bloomington
Drosophila Stock Center, and embryos were subjected to fluorescent ISH
with aGal4 probe or crossed toUAS-mCD8::GFP and immunostained with
anti-GFP as previously described (Pearson and Crews, 2014; Wheeler et al.,
2006).
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Schernhuber, K., Dickson, B. J. and Stark, A. (2014). Genome-scale
functional characterization of Drosophila developmental enhancers in vivo.
Nature 512, 91-95.
Langmead, B. and Salzberg, S. L. (2012). Fast gapped-read alignment with Bowtie
2. Nat. Methods 9, 357-359.
Lewis, J. O. and Crews, S. T. (1994). Genetic analysis of the Drosophila single-
minded gene reveals a central nervous system influence on muscle development.
Mech. Dev. 48, 81-91.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G.,
Abecasis, G. and Durbin, R. and 1000 Genome Project Data Processing
Subgroup (2009). The sequence alignment/map format and SAMtools.
Bioinformatics 25, 2078-2079.
Manning, L., Heckscher, E. S., Purice, M. D., Roberts, J., Bennett, A. L., Kroll,
J. R., Pollard, J. L., Strader, M. E., Lupton, J. R., Dyukareva, A. V. et al. (2012).
A resource for manipulating gene expression and analyzing cis-regulatory
modules in the Drosophila CNS. Cell Rep. 2, 1002-1013.
McKay, D. J. and Lieb, J. D. (2013). A common set of DNA regulatory elements
shapes Drosophila appendages. Dev. Cell 27, 306-318.
McLeay, R. C. and Bailey, T. L. (2010). Motif Enrichment Analysis: a unified
framework and an evaluation on ChIP data. BMC Bioinformatics 11, 165.
Meng, X., Brodsky, M. H. andWolfe, S. A. (2005). A bacterial one-hybrid system for
determining the DNA-binding specificity of transcription factors. Nat. Biotechnol.
23, 988-994.
Muralidhar, M. G., Callahan, C. A. and Thomas, J. B. (1993). Single-minded
regulation of genes in the embryonic midline of the Drosophila central nervous
system. Mech. Dev. 41, 129-138.
Nambu, J. R., Franks, R. G., Hu, S. and Crews, S. T. (1990). The single-minded
gene of Drosophila is required for the expression of genes important for the
development of CNS midline cells. Cell 63, 63-75.
Nambu, J. R., Lewis, J. L.,Wharton, K. A. andCrews, S. T. (1991). TheDrosophila
single-minded gene encodes a helix-loop-helix protein that acts as a master
regulator of CNS midline development. Cell 67, 1157-1167.
Pearson, J. C. and Crews, S. T. (2014). Enhancer diversity and the control of a
simple pattern of Drosophila CNS midline cell expression. Dev. Biol. 392,
466-482.
Quinlan, A. R. and Hall, I. M. (2010). BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841-842.
Robinson, M. D., McCarthy, D. J. and Smyth, G. K. (2010). edgeR: a Bioconductor
package for differential expression analysis of digital gene expression data.
Bioinformatics 26, 139-140.
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